467 | Humans |
370 | Pandemics |
310 | Betacoronavirus |
221 | Coronavirus Infections (epidemiology) |
218 | Pneumonia, Viral (epidemiology) |
203 | Coronavirus Infections (psychology) |
202 | Pneumonia, Viral (psychology) |
106 | Adult |
101 | Mental Health |
101 | Female |
94 | Pneumonia, Viral |
93 | Male |
92 | Coronavirus Infections |
75 | Pandemics (prevention & control) |
74 | Coronavirus Infections (prevention & control) |
72 | Pneumonia, Viral (prevention & control) |
49 | Middle Aged |
46 | Health Personnel (psychology) |
45 | Mental Health Services |
45 | Aged |
42 | Coronavirus Infections (complications) |
41 | Pneumonia, Viral (complications) |
39 | Adolescent |
38 | Surveys and Questionnaires |
38 | Disease Outbreaks |
37 | Young Adult |
36 | Risk Factors |
36 | Mental Disorders (therapy) |
36 | Child |
33 | Coronavirus |
33 | China (epidemiology) |
32 | Pneumonia, Viral (therapy) |
32 | Mental Disorders (epidemiology) |
32 | Coronavirus Infections (therapy) |
29 | Cross-Sectional Studies |
28 | Telemedicine |
28 | China |
26 | Anxiety (epidemiology) |
25 | Quarantine (psychology) |
25 | Coronavirus Infections (drug therapy) |
22 | Depression (epidemiology) |
22 | Adaptation, Psychological |
21 | Betacoronavirus (pathogenicity) |
21 | Anxiety (psychology) |
20 | Stress, Psychological |
20 | Pneumonia, Viral (transmission) |
20 | Pneumonia, Viral (drug therapy) |
20 | Coronavirus Infections (transmission) |
19 | Mental Health Services (organization & administration) |
19 | Health Services Accessibility |
19 | Betacoronavirus (isolation & purification) |
19 | Aged, 80 and over |
18 | Social Isolation |
18 | Public Health |
18 | Mental Disorders (psychology) |
18 | Depression (psychology) |
17 | Psychiatry |
17 | Coronavirus Infections (diagnosis) |
17 | Comorbidity |
16 | Stress, Psychological (etiology) |
16 | Psychological Distress |
16 | Pneumonia, Viral (diagnosis) |
15 | Social Support |
15 | Social Isolation (psychology) |
15 | Mental Disorders (complications) |
15 | Anxiety |
14 | Stress, Psychological (psychology) |
14 | Stress, Psychological (epidemiology) |
14 | Risk Assessment |
14 | Resilience, Psychological |
14 | Anxiety (etiology) |
13 | Vulnerable Populations |
13 | Health Personnel |
12 | Practice Guidelines as Topic |
12 | Internet |
12 | Interdisciplinary Research |
12 | Infection Control (methods) |
12 | Delivery of Health Care |
11 | Psychiatry (trends) |
11 | Mental Health (trends) |
11 | France (epidemiology) |
10 | United States |
10 | Psychiatry (methods) |
10 | Fear |
10 | Depression (etiology) |
10 | Communication |
9 | Quarantine |
9 | Psychiatric Status Rating Scales |
9 | Pneumonia, Viral (immunology) |
9 | Mental Disorders (etiology) |
9 | Emotions |
9 | Coronavirus Infections (virology) |
9 | Coronavirus Infections (immunology) |
9 | Communicable Disease Control |
9 | Anxiety Disorders (epidemiology) |
8 | Uncertainty |
8 | Telemedicine (methods) |
8 | Stress, Psychological (prevention & control) |
8 | Prevalence |
8 | Pregnancy |
8 | Pneumonia, Viral (virology) |
8 | Pneumonia, Viral (mortality) |
8 | Pandemics (statistics & numerical data) |
8 | Mental Health (statistics & numerical data) |
8 | Italy (epidemiology) |
8 | Infection Control |
8 | Global Health |
8 | Germany |
8 | Coronavirus Infections (mortality) |
8 | Anxiety Disorders (psychology) |
8 | Antiviral Agents (therapeutic use) |
8 | Age Factors |
7 | Universities |
7 | Treatment Outcome |
7 | Telemedicine (organization & administration) |
7 | Suicide (psychology) |
7 | Stress, Psychological (therapy) |
7 | Stress Disorders, Post-Traumatic (psychology) |
7 | Stress Disorders, Post-Traumatic (etiology) |
7 | Socioeconomic Factors |
7 | Psychotropic Drugs (adverse effects) |
7 | Pneumonia, Viral (physiopathology) |
7 | Italy |
7 | Infection Control (organization & administration) |
7 | Health Knowledge, Attitudes, Practice |
7 | Health Behavior |
7 | Disease Outbreaks (prevention & control) |
7 | Coronavirus Infections (physiopathology) |
6 | Vulnerable Populations (psychology) |
6 | United States (epidemiology) |
6 | Telemedicine (trends) |
6 | Suicide (statistics & numerical data) |
6 | Suicide (prevention & control) |
6 | Sleep Initiation and Maintenance Disorders (etiology) |
6 | Sleep Initiation and Maintenance Disorders (epidemiology) |
6 | Severity of Illness Index |
6 | Psychotherapy (methods) |
6 | Psychological Trauma (psychology) |
6 | Professional Role |
6 | Mental Disorders |
6 | Mental Disorders (drug therapy) |
6 | Logistic Models |
6 | Hydroxychloroquine (adverse effects) |
6 | Hospitals, Psychiatric |
6 | Hospitalization |
6 | Health Surveys |
6 | France |
6 | Drug Repositioning |
6 | Drug Interactions |
6 | Depression |
6 | Communicable Disease Control (methods) |
6 | Antiviral Agents (adverse effects) |
6 | Animals |
6 | Access to Information |
5 | Students (psychology) |
5 | Stress, Psychological (physiopathology) |
5 | Stress Disorders, Post-Traumatic (epidemiology) |
5 | Spain |
5 | Social Stigma |
5 | Sleep Initiation and Maintenance Disorders (psychology) |
5 | Schizophrenia (drug therapy) |
5 | Schizophrenia (complications) |
5 | Research Design |
5 | Quality of Life |
5 | Psychotherapy |
5 | Psychosocial Support Systems |
5 | Psychoneuroimmunology |
5 | Psychological Trauma (therapy) |
5 | Prisoners (psychology) |
5 | Pneumonia, Viral (economics) |
5 | Personnel, Hospital (psychology) |
5 | Parent-Child Relations |
5 | Pandemics (economics) |
5 | Mental Health Services (trends) |
5 | Mental Disorders (prevention & control) |
5 | Mental Disorders (diagnosis) |
5 | Interprofessional Relations |
5 | Inpatients |
5 | India (epidemiology) |
5 | Hospitals, Psychiatric (organization & administration) |
5 | Health Status Disparities |
5 | Health Services for the Aged (trends) |
5 | Health Services Needs and Demand |
5 | Epidemics |
5 | Coronavirus Infections (economics) |
5 | Caregivers (psychology) |
5 | Betacoronavirus (drug effects) |
5 | Antipsychotic Agents (adverse effects) |
5 | Aging (psychology) |
5 | Aging (physiology) |
4 | Videoconferencing |
4 | Time Factors |
4 | Telemedicine (standards) |
4 | Substance-Related Disorders (therapy) |
4 | Substance-Related Disorders (epidemiology) |
4 | Stress, Psychological (diagnosis) |
4 | Stress Disorders, Post-Traumatic |
4 | Social Media |
4 | Smartphone |
4 | Sleep Wake Disorders (etiology) |
4 | Sleep Wake Disorders (epidemiology) |
4 | Sex Factors |
4 | Psychotropic Drugs (therapeutic use) |
4 | Psychotropic Drugs (administration & dosage) |
4 | Psychotic Disorders (psychology) |
4 | Psychotic Disorders (etiology) |
4 | Psychotic Disorders (drug therapy) |
4 | Psychological Trauma (etiology) |
4 | Psychiatric Department, Hospital |
4 | Personal Protective Equipment |
4 | Patient Safety |
4 | Patient Isolation |
4 | Patient Isolation (psychology) |
4 | Parents (psychology) |
4 | Organizational Innovation |
4 | Occupational Health |
4 | Mental Health Services (supply & distribution) |
4 | Masks |
4 | Information Dissemination |
4 | Infectious Disease Transmission, Patient-to-Professional (prevention & control) |
4 | India |
4 | Hospital Units (organization & administration) |
4 | Healthcare Disparities |
4 | Health Status |
4 | Health Policy |
4 | Fear (psychology) |
4 | Evidence-Based Medicine |
4 | Editorial Policies |
4 | Depressive Disorder (epidemiology) |
4 | Dementia (therapy) |
4 | Dementia (epidemiology) |
4 | Delivery of Health Care (organization & administration) |
4 | Coronavirus Infections (pathology) |
4 | Coronavirus Infections (metabolism) |
4 | Clinical Laboratory Techniques |
4 | Chloroquine (adverse effects) |
4 | Change Management |
4 | Biomedical Research |
4 | Behavioral Symptoms (therapy) |
4 | Behavior, Addictive (psychology) |
4 | Behavior, Addictive (epidemiology) |
4 | Attitude of Health Personnel |
4 | Anxiety Disorders |
4 | Anxiety (therapy) |
4 | Antipsychotic Agents (therapeutic use) |
3 | World Health Organization |
3 | Workplace |
3 | United Kingdom (epidemiology) |
3 | Terminology as Topic |
3 | Systematic Reviews as Topic |
3 | Spain (epidemiology) |
3 | Social Distance |
3 | Social Change |
3 | Social Behavior |
3 | Sleep |
3 | Sleep Wake Disorders (psychology) |
3 | Sexual Health |
3 | Sexual Behavior |
3 | SARS Virus |
3 | Risk |
3 | Research |
3 | Refugees (psychology) |
3 | Randomized Controlled Trials as Topic |
3 | Public Policy |
3 | Psychotic Disorders (virology) |
3 | Psychotic Disorders (therapy) |
3 | Psychotic Disorders (diagnosis) |
3 | Psychiatric Department, Hospital (organization & administration) |
3 | Protective Devices |
3 | Pneumonia, Viral (pathology) |
3 | Pneumonia, Viral (metabolism) |
3 | Pilot Projects |
3 | Physicians (psychology) |
3 | Physician's Role |
3 | Personal Protective Equipment (trends) |
3 | Personal Protective Equipment (supply & distribution) |
3 | Patient Selection |
3 | Patient Health Questionnaire |
3 | Patient Compliance |
3 | Patient Care Team |
3 | Patient Care Management (organization & administration) |
3 | Patient Care Management (methods) |
3 | Occupations |
3 | Nursing Homes |
3 | Nursing Homes (organization & administration) |
3 | New York City (epidemiology) |
3 | Nervous System Diseases (etiology) |
3 | Mortality |
3 | Mobile Applications |
3 | Mental Health Services (standards) |
3 | Medical Staff, Hospital (statistics & numerical data) |
3 | Medical Staff, Hospital (psychology) |
3 | Medical Staff (psychology) |
3 | Mass Screening |
3 | Loneliness (psychology) |
3 | Life Change Events |
3 | Leadership |
3 | Iran |
3 | Intersectoral Collaboration |
3 | International Cooperation |
3 | Incidence |
3 | Hydroxychloroquine (therapeutic use) |
3 | Health Services Accessibility (trends) |
3 | Health Personnel (statistics & numerical data) |
3 | Health Communication |
3 | Global Health (trends) |
3 | Geriatrics |
3 | Geriatric Psychiatry (methods) |
3 | Feeding and Eating Disorders (psychology) |
3 | Family (psychology) |
3 | Depressive Disorder (psychology) |
3 | Delivery of Health Care (methods) |
3 | Death |
3 | Cost of Illness |
3 | Continuity of Patient Care |
3 | Consensus |
3 | Communicable Disease Control (organization & administration) |
3 | Cognitive Behavioral Therapy (methods) |
3 | Cognition |
3 | Clozapine (therapeutic use) |
3 | Clozapine (adverse effects) |
3 | Clinical Trials as Topic |
3 | Civil Defense |
3 | Child Abuse (psychology) |
3 | Child Abuse (prevention & control) |
3 | Case-Control Studies |
3 | Canada (epidemiology) |
3 | Burnout, Professional (psychology) |
3 | Bioethical Issues |
3 | Behavioral Symptoms (etiology) |
3 | Autistic Disorder (psychology) |
3 | Autistic Disorder (complications) |
3 | Attitude to Health |
3 | Anxiety (prevention & control) |
3 | Anxiety (diagnosis) |
3 | Antiviral Agents (pharmacology) |
3 | Antipsychotic Agents (administration & dosage) |
3 | Analgesics, Opioid (therapeutic use) |
3 | Activities of Daily Living |
2 | Visitors to Patients |
2 | United Kingdom |
2 | Triage |
2 | Travel |
2 | Transients and Migrants |
2 | Transgender Persons (psychology) |
2 | Terminal Care |
2 | Telephone |
2 | Telemedicine (statistics & numerical data) |
2 | Telemedicine (instrumentation) |
2 | Taiwan |
2 | Taiwan (epidemiology) |
2 | Suicide |
2 | Suicide, Attempted |
2 | Suicide (trends) |
2 | Suicidal Ideation |
2 | Substance-Related Disorders |
2 | Substance Withdrawal Syndrome (diagnosis) |
2 | Stress, Psychological (complications) |
2 | Stress Disorders, Traumatic (therapy) |
2 | Stress Disorders, Post-Traumatic (therapy) |
2 | Stress Disorders, Post-Traumatic (prevention & control) |
2 | Stereotyping |
2 | Societies, Medical |
2 | Social Marginalization |
2 | Social Conditions |
2 | Smoking (epidemiology) |
2 | Sleep Initiation and Maintenance Disorders (therapy) |
2 | Single-Blind Method |
2 | Severe Acute Respiratory Syndrome |
2 | Severe Acute Respiratory Syndrome (psychology) |
2 | Severe Acute Respiratory Syndrome (epidemiology) |
2 | Self Concept |
2 | Schizophrenic Psychology |
2 | Retrospective Studies |
2 | Respiratory Insufficiency (etiology) |
2 | Respiration, Artificial (methods) |
2 | Respiration (drug effects) |
2 | Resource Allocation |
2 | Residential Facilities (standards) |
2 | Republic of Korea |
2 | Renin-Angiotensin System (physiology) |
2 | Remote Consultation |
2 | Remote Consultation (methods) |
2 | Religion |
2 | Religion and Psychology |
2 | Relaxation Therapy |
2 | Receptors, Virus (metabolism) |
2 | Quarantine (statistics & numerical data) |
2 | Publishing (trends) |
2 | Public Health (methods) |
2 | Psychotherapy (statistics & numerical data) |
2 | Psychotherapy (organization & administration) |
2 | Psychopathology |
2 | Psychology, Child |
2 | Psychology, Adolescent |
2 | Psychiatry (organization & administration) |
2 | Psychiatry (education) |
2 | Psychiatric Rehabilitation |
2 | Psychiatric Department, Hospital (trends) |
2 | Protein Domains |
2 | Prospective Studies |
2 | Prognosis |
2 | Procedures and Techniques Utilization |
2 | Prisons |
2 | Pregnant Women (psychology) |
2 | Pregnancy Complications (diagnosis) |
2 | Postpartum Period |
2 | Physician-Patient Relations |
2 | Personnel Staffing and Scheduling |
2 | Personal Satisfaction |
2 | Periodicals as Topic |
2 | Peptidyl-Dipeptidase A (metabolism) |
2 | Patients (psychology) |
2 | Patient Discharge |
2 | Patient Care |
2 | Patient Care Management (trends) |
2 | Patient Advocacy |
2 | Patient Acceptance of Health Care |
2 | Parkinson Disease (complications) |
2 | Panic Disorder (drug therapy) |
2 | Opioid-Related Disorders (drug therapy) |
2 | Occupational Diseases (therapy) |
2 | Occupational Diseases (etiology) |
2 | Obsessive-Compulsive Disorder |
2 | Object Attachment |
2 | Neurosecretory Systems (physiopathology) |
2 | Neurodegenerative Diseases (immunology) |
2 | Neurodegenerative Diseases (etiology) |
2 | Nervous System Diseases (virology) |
2 | Nervous System Diseases (therapy) |
2 | Nervous System Diseases (physiopathology) |
2 | Morals |
2 | Mindfulness |
2 | Mentally Ill Persons |
2 | Mental Health Services (statistics & numerical data) |
2 | Mental Disorders (physiopathology) |
2 | Mental Disorders (chemically induced) |
2 | Mental Competency (psychology) |
2 | Mass Media |
2 | Longitudinal Studies |
2 | Long QT Syndrome (chemically induced) |
2 | Iran (epidemiology) |
2 | Internet Access |
2 | Internet (statistics & numerical data) |
2 | Internationality |
2 | Injections |
2 | Infectious Disease Transmission, Professional-to-Patient |
2 | Immunologic Factors (adverse effects) |
2 | Hypnotics and Sedatives (therapeutic use) |
2 | Hydroxychloroquine (administration & dosage) |
2 | Housing |
2 | Hospitals |
2 | Hospitalization (trends) |
2 | Hospital Restructuring |
2 | Homes for the Aged (organization & administration) |
2 | Homeless Persons (psychology) |
2 | Health Services for the Aged (standards) |
2 | Health Services for the Aged (organization & administration) |
2 | Health Services Research |
2 | Health Services Needs and Demand (statistics & numerical data) |
2 | Health Services Accessibility (standards) |
2 | Health Services Accessibility (organization & administration) |
2 | Health Promotion (methods) |
2 | Health Equity |
2 | Hand Hygiene |
2 | Hand Disinfection |
2 | Hallucinations (etiology) |
2 | Guilt |
2 | Guidelines as Topic |
2 | Grief |
2 | Geriatric Psychiatry (trends) |
2 | Feeding and Eating Disorders |
2 | Feeding and Eating Disorders (therapy) |
2 | Feeding and Eating Disorders (etiology) |
2 | Feeding Behavior (psychology) |
2 | Exercise |
2 | Exercise (psychology) |
2 | Endocytosis (drug effects) |
2 | Employment (psychology) |
2 | Emigrants and Immigrants |
2 | Emergency Service, Hospital (organization & administration) |
2 | Emergency Medical Services |
2 | Emergencies |
2 | Electroconvulsive Therapy (standards) |
2 | Electroconvulsive Therapy (methods) |
2 | Elder Abuse (psychology) |
2 | Elder Abuse (prevention & control) |
2 | Education, Distance |
2 | Dyspnea (psychology) |
2 | Dyspnea (etiology) |
2 | Drug Therapy, Combination |
2 | Drug Prescriptions |
2 | Drug Combinations |
2 | Double-Blind Method |
2 | Domestic Violence |
2 | Domestic Violence (psychology) |
2 | Domestic Violence (prevention & control) |
2 | Developing Countries |
2 | Depression (therapy) |
2 | Depression (immunology) |